Clinical predictors of unrecognized bipolar I and II disorders

Bipolar Disorders

Volumn 10, Issue 2, 2008, Pages 238-244

  Mantere, Outi ^a,b   Suominen, Kirsi ^a,b   Arvilommi, Petri ^a,b   Valtonen, Hanna ^a,b   Leppämäki, Sami ^a,c   Isometsä, Erkki ^a,c  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b JORVI HOSPITAL   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Bipolar I disorder; BipolarII disorder; Mood Disorder Questionnaire; Rec ognition; Screening

Indexed keywords

ADULT; ARTICLE; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; FEMALE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; HYPOMANIA; MAJOR CLINICAL STUDY; MALE; MANIA; MOOD DISORDER QUESTIONNAIRE; OUTPATIENT; PREDICTION; PRIORITY JOURNAL; PSYCHOSIS; PSYCHOTHERAPY; QUESTIONNAIRE; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS;

ADULT; BIPOLAR DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC ERRORS; FEMALE; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 42049119293     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/j.1399-5618.2007.00501.x     Document Type: Article

References (38)

1. Mantere O, Suominen K, Leppamaki S, Valtonen H, Arvilommi P, Isometsa E. The clinical characteristics of DSM-IV bipolar I and II disorders: baseline findings from the Jorvi Bipolar Study (JoBS). Bipolar Disord 2004; 6: 395-405.
2. Hantouche EG, Akiskal HS, Lancrenon S et al. Systematic clinical methodology for validating bipolar II disorder: Data in mid-stream from a French national multi-site study (EPIDEP). J Affect Disord 1998; 50: 163-173.
3. ten Have M, Vollebergh W, Bijl R, Nolen WA. Bipolar disorder in the general population in the Netherlands (prevalence, consequences and care utilization): Results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS). J Affect Disord 2002; 68: 203-213.
4. Hirschfeld RM, Lewis L, Vornik LA. Perceptions and impact of bipolar disorder: How far have we really come? Results of the National Depressive and Manic-depressive Association 2000 survey of individuals with bipolar disorder. J Clin Psychiatry 2003; 64: 161-174.
5. Baldessarini RJ, Tondo L, Hennen J. Treatment-latency and previous episodes: Relationships to pretreatment morbidity and response to maintenance treatment in bipolar I and II disorders. Bipolar Disord 2003; 5: 169-179.
6. Birnbaum HG, Shi L, Dial E, Oster EF, Greenberg PE, Mallett DA. Economic consequences of not recognizing bipolar disorder patients: A cross-sectional descriptive analysis. J Clin Psychiatry 2003; 64: 1201-1209.
7. Shi L, Thiebaud P, McCombs JS. The impact of unrecognized bipolar disorders for patients treated for depression with antidepressants in the fee-for-services California Medicaid (Medi-Cal) program. J Affect Disord 2004; 82: 373-383.
8. Akiskal HS, Hantouche EG, Allilaire JF. Bipolar II with and without cyclothymic temperament: 'dark' and 'sunny' expressions of soft bipolarity. J Affect Disord 2003; 73: 49-57.
9. Akiskal HS, Hantouche EG, Bourgeois ML et al. Gender, temperament and the clinical picture in dysphoric mixed mania: Findings from a French national study (EPIMAN). J Affect Disord 1998; 50: 175-186.
10. Goldberg JF, Ernst CL. Features associated with the delayed initiation of mood stabilizers at illness onset in bipolar disorder. J Clin Psychiatry 2002; 63: 985-991.
11. Baethge C, Tondo L, Bratti IM et al. Prophylaxis latency and outcome in bipolar disorders. Can J Psychiatry 2003; 48: 449-457.
12. Lish JD, Dime-Meenan S, Whybrow PC, Price RA, Hirschfeld RM. The National Depressive and Manic-depressive Association (DMDA) survey of bipolar members. J Affect Disord 1994; 31: 281-294.
13. Baethge C, Smolka MN, Gruschka P et al. Does prophylaxis-delay in bipolar disorder influence outcome? Results from a long-term study of 147 patients. Acta Psychiatr Scand 2003; 107: 260-267.
14. Hambrecht M. A second case of schizophrenia in the family: Is it observed differently? Eur Arch Psychiatry Clin Neurosci 1995; 245: 267-269.
15. Bhugra D, Flick GR. Pathways to care for patients with bipolar disorder. Bipolar Disord 2005; 7: 236-245.
16. Pallanti S, Quercioli L, Pazzagli A et al. Awareness of illness and subjective experience of cognitive complaints in patients with bipolar I and bipolar II disorder. Am J Psychiatry 1999; 156: 1094-1096.
17. Ghaemi SN. Insight and psychiatric disorders: A review of the literature, with a focus on its clinical relevance for bipolar disorder. Psychiatr Ann 1997; 27: 782-790.
18. Mojtabai R, Olfson M, Mechanic D. Perceived need and help-seeking in adults with mood, anxiety, or substance use disorders. Arch Gen Psychiatry 2002; 59: 77-84.
19. Hirschfeld RM, Williams JB, Spitzer RL et al. Development and validation of a screening instrument for bipolar spectrum disorder: The Mood Disorder Questionnaire. Am J Psychiatry 2000; 157: 1873-1875.
20. Isometsa E, Suominen K, Mantere O et al. The mood disorder questionnaire improves recognition of bipolar disorder in psychiatric care. BMC Psychiatry 2003; 3: 8.
21. Zimmerman M, Posternak MA, Chelminski I, Solomon DA. Using questionnaires to screen for psychiatric disorders: A comment on a study of screening for bipolar disorder in the community. J Clin Psychiatry 2004; 65: 605-610; discussion 721.
22. Benazzi F. Improving the Mood Disorder Questionnaire to detect bipolar II disorder. Can J Psychiatry 2003; 48: 770-771.
23. Kessler RC, Rubinow DR, Holmes C, Abelson JM, Zhao S. The epidemiology of DSM-III-R bipolar I disorder in a general population survey. Psychol Med 1997; 27: 1079-1089.
24. Morselli PL, Elgie R. GAMIAN-Europe/BEAM survey I - global analysis of a patient questionnaire circulated to 3,450 members of 12 European advocacy groups operating in the field of mood disorders. Bipolar Disord 2003; 5: 265-278.
25. Ghaemi SN, Sachs GS, Chiou AM, Pandurangi AK, Goodwin K. Is bipolar disorder still underdiagnosed? Are antidepressants overutilized? J Affect Disord 1999; 52: 135-144.
26. Ghaemi SN, Boiman EE, Goodwin FK. Diagnosing bipolar disorder and the effect of antidepressants: A naturalistic study. J Clin Psychiatry 2000; 61: 804-808; quiz 809.
27. Tondo L, Baldessarini RJ, Hennen J, Floris G. Lithium maintenance treatment of depression and mania in bipolar I and bipolar II disorders. Am J Psychiatry 1998; 155: 638-645.
28. Judd LL, Akiskal HS, Schettler PJ et al. A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry 2003; 60: 261-269.
29. Judd LL, Akiskal HS, Schettler PJ et al. Psychosocial disability in the course of bipolar I and II disorders: A prospective, comparative, longitudinal study. Arch Gen Psychiatry 2005; 62: 1322-1330.
30. Akiskal HS, Benazzi F. optimizing the detection of bipolar II disorder in outpatient private practice: Toward a systematization of clinical diagnostic wisdom. J Clin Psychiatry 2005; 66: 914-921.
31. Angst J. Hypomania. Apropos of a cohort of young patients. Encephale 1992; 18: 23-29.
32. Eckblad M, Chapman LJ. Development and validation of a scale for hypomanic personality. J Abnorm Psychol 1986; 95: 214-222.
33. Hantouche EG, Angst J, Akiskal HS. Factor structure of hypomania: interrelationships with cyclothymia and the soft bipolar spectrum. J Affect Disord 2003; 73: 39-47.
34. Meyer TD, Hautzinger M. Screening for bipolar disorders using the Hypomanic Personality Scale. J Affect Disord 2003; 75: 149-154.
35. Nasr S, Popli A, Wendt B. Can the MiniSCID improve the detection of bipolarity in private practice? J Affect Disord 2005; 86: 289-293.
36. Benazzi F, Akiskal HS. A downscaled practical measure of mood lability as a screening tool for bipolar II. J Affect Disord 2005; 84: 225-232.
37. Baldassano CF. Assessment tools for screening and monitoring bipolar disorder. Bipolar Disord 2005; 7 (Suppl. 1): 8-15.
38. Serretti A, Olgiati P. Profiles of 'manic' symptoms in bipolar I, bipolar II and major depressive disorders. J Affect Disord 2005; 84: 159-166.